Short answer
DocGo Inc. (DCGO) filed an 8-K current report with the SEC on October 5, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 8.01 (Other Events), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities). Refinanced $52M existing debt and added $12.5M Term Loan B immediately.
DocGo Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Refinanced $52M existing debt and added $12.5M Term Loan B immediately
- Additional $12.5M Term Loan C tied to merger completion, plus $25M delayed-draw capacity through December 31, 2027
- High-cost debt: Term SOFR with 3.50% floor plus 7.50% margin, maturing December 6, 2029
- First-priority liens on substantially all personal property, increasing lender recovery priority
- Lender received fully vested warrant for 4M shares at $0.5039, exercisable for 10 years, creating potential dilution
- Stock repurchases capped at $40M and require administrative-agent consent plus covenant compliance
Item 1.02 · Termination of a Material Definitive Agreement
- Existing revolving credit facility terminated October 1, 2026 before new Credit Agreement entry
- All undrawn commitments canceled, eliminating access to the prior revolver
- Related guarantees and liens discharged, releasing collateral and associated security obligations
Item 3.02 · Unregistered Sales of Equity Securities
- Warrant issued to the administrative agent as consideration for entering the Credit Agreement
- Potential warrant shares represent future equity dilution, with terms incorporated from Item 1.01
- Private-placement exemption under Securities Act Section 4(a)(2), without underwriters or commissions
- Warrant and shares restricted from U.S. resale absent registration or an exemption
- Common shares outstanding totaled 98,992,347 as of October 1, 2026
Item 8.01 · Other Events
- Ambulnz begins managing Hicuity’s non-clinical operations effective October 1, 2026
- Consulting Services Agreement closing conditions satisfied, activating the arrangement
- Operational handoff may affect Hicuity’s cost structure and execution, with financial terms not disclosed in this item
Other items in this filing:
- Item 2.03: Creation of a Direct Financial Obligation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DocGo Inc. 8-K filings
Get the next DCGO 8-K as it lands
Follow DCGO for push alerts, or ask the research agent what this filing means.